Sunitinib to Treat Recurrent Brain Cancer

Stopped The study was terminated based on results of an interim analysis for futility.

Conditions

• Glioblastoma Multiforme
• Malignant Gliomas
• Anaplastic Gliomas

Interventions

• DRUG: Sutent (sunitinib)

Sponsor

National Cancer Institute (NCI)